Lexology October 17, 2023
McDermott Will & Emery

Introduction

The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government.

Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. PBMs administer prescription drug benefits and seek discounts for insurers as standalone plans, such as Medicare Part D plans, or as entities embedded in commercial insurance products, including Medicare Advantage (MA), Medicaid Managed Care Organizations and employer-sponsored coverage. PBMs often create formularies, negotiate rebates with drug manufacturers, process claims, create pharmacy networks, review drug utilization, and manage mail-order specialty pharmacies. PBMs most often play...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation
Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025?
AI in Pharma: Where, When, and How Executives are Considering it
Grifols linked to €7bn takeover offer from Brookfield
Pharma Pulse 11/19/24: Is Any Data Better Than No Data? Exploring Emerging Vitiligo Therapies & more

Share This Article